共 50 条
- [41] A global transcriptome analysis of pancreatic cancer cells distinguishes between acute and acquired PARP inhibitor resistance mechanisms[J]. CANCER RESEARCH, 2019, 79 (13)论文数: 引用数: h-index:机构:McCoy, Matthew论文数: 0 引用数: 0 h-index: 0机构: Georgetown Univ, Washington, DC USA Thomas Jefferson Univ, Philadelphia, PA 19107 USAAgostini, Lebaron A.论文数: 0 引用数: 0 h-index: 0机构: Thomas Jefferson Univ, Philadelphia, PA 19107 USA Thomas Jefferson Univ, Philadelphia, PA 19107 USA论文数: 引用数: h-index:机构:Madhavan, Subha论文数: 0 引用数: 0 h-index: 0机构: Georgetown Univ, Washington, DC USA Thomas Jefferson Univ, Philadelphia, PA 19107 USAPishvaian, Michael论文数: 0 引用数: 0 h-index: 0机构: Georgetown Univ, Washington, DC USA Thomas Jefferson Univ, Philadelphia, PA 19107 USAAddya, Sankar论文数: 0 引用数: 0 h-index: 0机构: Thomas Jefferson Univ, Philadelphia, PA 19107 USA Thomas Jefferson Univ, Philadelphia, PA 19107 USA论文数: 引用数: h-index:机构:Gurevich, Maria R.论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Tel Aviv, Israel Thomas Jefferson Univ, Philadelphia, PA 19107 USAStossel, Chani论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Tel Aviv, Israel Thomas Jefferson Univ, Philadelphia, PA 19107 USAGolan, Talia论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Tel Aviv, Israel Thomas Jefferson Univ, Philadelphia, PA 19107 USAYeo, Charles J.论文数: 0 引用数: 0 h-index: 0机构: Thomas Jefferson Univ, Philadelphia, PA 19107 USA Thomas Jefferson Univ, Philadelphia, PA 19107 USABrody, Jonathan R.论文数: 0 引用数: 0 h-index: 0机构: Thomas Jefferson Univ, Philadelphia, PA 19107 USA Thomas Jefferson Univ, Philadelphia, PA 19107 USA
- [42] Increasing PARP inhibitor activity via several mechanisms of action[J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (SUPPL 1) : S22 - S22Arkenau, Hendrik-Tobias论文数: 0 引用数: 0 h-index: 0机构: Sarah Cannon Res Inst, London, England Sarah Cannon Res Inst, London, England
- [43] Mechanisms of aromatase inhibitor resistance[J]. Nature Reviews Cancer, 2015, 15 : 261 - 275Cynthia X. Ma论文数: 0 引用数: 0 h-index: 0机构: Siteman Cancer Center,Division of Oncology, Department of MedicineTomás Reinert论文数: 0 引用数: 0 h-index: 0机构: Siteman Cancer Center,Division of Oncology, Department of MedicineIzabela Chmielewska论文数: 0 引用数: 0 h-index: 0机构: Siteman Cancer Center,Division of Oncology, Department of MedicineMatthew J. Ellis论文数: 0 引用数: 0 h-index: 0机构: Siteman Cancer Center,Division of Oncology, Department of Medicine
- [44] Mechanisms of aromatase inhibitor resistance[J]. NATURE REVIEWS CANCER, 2015, 15 (05) : 261 - 275Ma, Cynthia X.论文数: 0 引用数: 0 h-index: 0机构: Washington Univ, Sch Med, Dept Med, Siteman Canc Ctr,Div Oncol, St Louis, MO 63110 USA Washington Univ, Sch Med, Dept Med, Siteman Canc Ctr,Div Oncol, St Louis, MO 63110 USAReinert, Tomas论文数: 0 引用数: 0 h-index: 0机构: Inst Nacl Canc INCA, Dept Med Oncol, BR-20230130 Rio De Janeiro, Brazil Washington Univ, Sch Med, Dept Med, Siteman Canc Ctr,Div Oncol, St Louis, MO 63110 USAChmielewska, Izabela论文数: 0 引用数: 0 h-index: 0机构: Med Univ Lublin, Dept Pneumonol Oncol & Allergol, PL-20954 Lublin, Poland Washington Univ, Sch Med, Dept Med, Siteman Canc Ctr,Div Oncol, St Louis, MO 63110 USAEllis, Matthew J.论文数: 0 引用数: 0 h-index: 0机构: Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA Washington Univ, Sch Med, Dept Med, Siteman Canc Ctr,Div Oncol, St Louis, MO 63110 USA
- [45] Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models[J]. NATURE COMMUNICATIONS, 2020, 11 (01)Kim, Hyoung论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USA Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USAXu, Haineng论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USA Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USAGeorge, Erin论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USA Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USAHallberg, Dorothy论文数: 0 引用数: 0 h-index: 0机构: Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Baltimore, MD 21287 USA Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USAKumar, Sushil论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USA Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USAJagannathan, Veena论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USAMedvedev, Sergey论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USA Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USAKinose, Yasuto论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USA Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USADevins, Kyle论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USAVerma, Priyanka论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USALy, Kevin论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USA Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USAWang, Yifan论文数: 0 引用数: 0 h-index: 0机构: Fox Chase Canc Ctr, Mol Therapeut Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USAGreenberg, Roger A.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USASchwartz, Lauren论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USAJohnson, Neil论文数: 0 引用数: 0 h-index: 0机构: Fox Chase Canc Ctr, Mol Therapeut Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USAScharpf, Robert B.论文数: 0 引用数: 0 h-index: 0机构: Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Baltimore, MD 21287 USA Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USAMills, Gordon B.论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Sch Med, Portland, OR 97239 USA Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USAZhang, Rugang论文数: 0 引用数: 0 h-index: 0机构: Wistar Inst Anat & Biol, Gene Express & Regulat Program, 3601 Spruce St, Philadelphia, PA 19104 USA Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USAVelculescu, Victor E.论文数: 0 引用数: 0 h-index: 0机构: Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Baltimore, MD 21287 USA Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USABrown, Eric J.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USASimpkins, Fiona论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USA Univ Penn, Penn Ovarian Canc Res Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USA
- [46] Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models[J]. Nature Communications, 11Hyoung Kim论文数: 0 引用数: 0 h-index: 0机构: University of Pennsylvania,Penn Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics and GynecologyHaineng Xu论文数: 0 引用数: 0 h-index: 0机构: University of Pennsylvania,Penn Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics and GynecologyErin George论文数: 0 引用数: 0 h-index: 0机构: University of Pennsylvania,Penn Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics and GynecologyDorothy Hallberg论文数: 0 引用数: 0 h-index: 0机构: University of Pennsylvania,Penn Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics and GynecologySushil Kumar论文数: 0 引用数: 0 h-index: 0机构: University of Pennsylvania,Penn Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics and GynecologyVeena Jagannathan论文数: 0 引用数: 0 h-index: 0机构: University of Pennsylvania,Penn Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics and GynecologySergey Medvedev论文数: 0 引用数: 0 h-index: 0机构: University of Pennsylvania,Penn Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics and GynecologyYasuto Kinose论文数: 0 引用数: 0 h-index: 0机构: University of Pennsylvania,Penn Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics and GynecologyKyle Devins论文数: 0 引用数: 0 h-index: 0机构: University of Pennsylvania,Penn Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics and GynecologyPriyanka Verma论文数: 0 引用数: 0 h-index: 0机构: University of Pennsylvania,Penn Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics and GynecologyKevin Ly论文数: 0 引用数: 0 h-index: 0机构: University of Pennsylvania,Penn Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics and GynecologyYifan Wang论文数: 0 引用数: 0 h-index: 0机构: University of Pennsylvania,Penn Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics and GynecologyRoger A. Greenberg论文数: 0 引用数: 0 h-index: 0机构: University of Pennsylvania,Penn Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics and GynecologyLauren Schwartz论文数: 0 引用数: 0 h-index: 0机构: University of Pennsylvania,Penn Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics and GynecologyNeil Johnson论文数: 0 引用数: 0 h-index: 0机构: University of Pennsylvania,Penn Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics and GynecologyRobert B. Scharpf论文数: 0 引用数: 0 h-index: 0机构: University of Pennsylvania,Penn Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics and GynecologyGordon B. Mills论文数: 0 引用数: 0 h-index: 0机构: University of Pennsylvania,Penn Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics and GynecologyRugang Zhang论文数: 0 引用数: 0 h-index: 0机构: University of Pennsylvania,Penn Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics and GynecologyVictor E. Velculescu论文数: 0 引用数: 0 h-index: 0机构: University of Pennsylvania,Penn Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics and GynecologyEric J. Brown论文数: 0 引用数: 0 h-index: 0机构: University of Pennsylvania,Penn Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics and GynecologyFiona Simpkins论文数: 0 引用数: 0 h-index: 0机构: University of Pennsylvania,Penn Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology
- [47] PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib[J]. Scientific Reports, 12Xia Ding论文数: 0 引用数: 0 h-index: 0机构: Pfizer,Oncology Research UnitZhou Zhu论文数: 0 引用数: 0 h-index: 0机构: Pfizer,Oncology Research UnitJohn Lapek论文数: 0 引用数: 0 h-index: 0机构: Pfizer,Oncology Research UnitElizabeth A. McMillan论文数: 0 引用数: 0 h-index: 0机构: Pfizer,Oncology Research UnitAlexander Zhang论文数: 0 引用数: 0 h-index: 0机构: Pfizer,Oncology Research UnitChi-Yeh Chung论文数: 0 引用数: 0 h-index: 0机构: Pfizer,Oncology Research UnitSara Dubbury论文数: 0 引用数: 0 h-index: 0机构: Pfizer,Oncology Research UnitJennifer Lapira论文数: 0 引用数: 0 h-index: 0机构: Pfizer,Oncology Research UnitSarah Firdaus论文数: 0 引用数: 0 h-index: 0机构: Pfizer,Oncology Research UnitXiaolin Kang论文数: 0 引用数: 0 h-index: 0机构: Pfizer,Oncology Research UnitJingjin Gao论文数: 0 引用数: 0 h-index: 0机构: Pfizer,Oncology Research UnitJon Oyer论文数: 0 引用数: 0 h-index: 0机构: Pfizer,Oncology Research UnitJohn Chionis论文数: 0 引用数: 0 h-index: 0机构: Pfizer,Oncology Research UnitRobert A. Rollins论文数: 0 引用数: 0 h-index: 0机构: Pfizer,Oncology Research UnitLianjie Li论文数: 0 引用数: 0 h-index: 0机构: Pfizer,Oncology Research UnitSherry Niessen论文数: 0 引用数: 0 h-index: 0机构: Pfizer,Oncology Research UnitShubha Bagrodia论文数: 0 引用数: 0 h-index: 0机构: Pfizer,Oncology Research UnitLianglin Zhang论文数: 0 引用数: 0 h-index: 0机构: Pfizer,Oncology Research UnitTodd VanArsdale论文数: 0 引用数: 0 h-index: 0机构: Pfizer,Oncology Research Unit
- [48] Assessing the impact of immune therapy in the setting of PARP inhibitor resistance[J]. GYNECOLOGIC ONCOLOGY, 2020, 159 (02) : E11 - E12Miller, Marina Delazari论文数: 0 引用数: 0 h-index: 0机构: Univ New Mexico, Albuquerque, NM 87131 USA Univ New Mexico, Albuquerque, NM 87131 USAKinjyo, Ichiko论文数: 0 引用数: 0 h-index: 0机构: Univ New Mexico, Albuquerque, NM 87131 USA Univ New Mexico, Albuquerque, NM 87131 USAAdams, Sarah Foster论文数: 0 引用数: 0 h-index: 0机构: Univ New Mexico, Albuquerque, NM 87131 USA Univ New Mexico, Albuquerque, NM 87131 USA
- [49] PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib[J]. SCIENTIFIC REPORTS, 2022, 12 (01)Ding, Xia论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USAZhu, Zhou论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA AstraZeneca Inc, Gaithersburg, MD 20878 USA Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USALapek, John论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA Belharra Therapeut Inc, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USAMcMillan, Elizabeth A.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA Odyssey Therapeut, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USAZhang, Alexander论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USAChung, Chi-Yeh论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USADubbury, Sara论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA Bristol Myers Squibb, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USALapira, Jennifer论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USAFirdaus, Sarah论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USAKang, Xiaolin论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USAGao, Jingjin论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA Turning Point Therapeut, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USAOyer, Jon论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USAChionis, John论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA Genesis Therapeut, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USARollins, Robert A.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USALi, Lianjie论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USANiessen, Sherry论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA Belharra Therapeut Inc, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USABagrodia, Shubha论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USAZhang, Lianglin论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USAVanArsdale, Todd论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA Pfizer Inc, Oncol Res Unit, San Diego, CA 92121 USA
- [50] Reversing PARP inhibitor resistance by targeting the replication stress response[J]. CANCER RESEARCH, 2019, 79 (13)O'Connor, Mark J.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cambridge, England AstraZeneca, Cambridge, EnglandCruz, Cristina论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Inst Oncol, Barcelona, Spain AstraZeneca, Cambridge, EnglandCastroviejo-Bermejo, Marta论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Inst Oncol, Barcelona, Spain AstraZeneca, Cambridge, EnglandPolanska, Urszula M.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cambridge, England AstraZeneca, Cambridge, EnglandJones, Gemma N.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cambridge, England AstraZeneca, Cambridge, EnglandWang, Anderson论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cambridge, England AstraZeneca, Cambridge, EnglandLai, Zhongwu论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Waltham, MA USA AstraZeneca, Cambridge, EnglandForment, Josep论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cambridge, England AstraZeneca, Cambridge, EnglandBulusu, Krishna论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cambridge, England AstraZeneca, Cambridge, EnglandLlop-Guevara, Alba论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Inst Oncol, Barcelona, Spain AstraZeneca, Cambridge, EnglandDougherty, Brian论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Waltham, MA USA AstraZeneca, Cambridge, EnglandSaura, Cristina论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Inst Oncol, Barcelona, Spain AstraZeneca, Cambridge, EnglandBrough, Rachel论文数: 0 引用数: 0 h-index: 0机构: Inst Canc Res, London, England AstraZeneca, Cambridge, EnglandLord, Chris J.论文数: 0 引用数: 0 h-index: 0机构: Inst Canc Res, London, England AstraZeneca, Cambridge, EnglandBruna, Alejandra论文数: 0 引用数: 0 h-index: 0机构: Canc Res UK, Cambridge, England AstraZeneca, Cambridge, EnglandCaldas, Carlos论文数: 0 引用数: 0 h-index: 0机构: Canc Res UK, Cambridge, England AstraZeneca, Cambridge, EnglandFawell, Stephen论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Waltham, MA USA AstraZeneca, Cambridge, EnglandBarrett, J. Carl论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Waltham, MA USA AstraZeneca, Cambridge, EnglandCritchlow, Susan E.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cambridge, England AstraZeneca, Cambridge, EnglandBalmana, Judith论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Inst Oncol, Barcelona, Spain AstraZeneca, Cambridge, EnglandCadogan, Elaine论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cambridge, England AstraZeneca, Cambridge, EnglandSerra, Violeta论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Cambridge, England